panitumumab
amgen,takeda
['crcsm', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'paradigm']
my initial reactions to paradigm 1) i m not yet ready to jettison sidedness as absolutely crucial in treatment decisions 2) i still haven t forgotten about calbg 80405 3) i may feel slightly better now about new epoc #asco22 #crcsm 
Director, GI Oncology, @Intermountain. Interests: neuroendocrine tumors, cancer syndromes, empathy (even had a Whipple myself). Tweets my own.